Quirós CS

Idioma: Español
Referencias bibliográficas: 38
Paginas: 11-21
Archivo PDF: 668.08 Kb.

RESUMEN

Las infecciones asociadas a enterobacterias se presentan con gran frecuencia tanto en pacientes provenientes de la comunidad como en pacientes hospitalizados. Dentro de este gran grupo de bacterias, los especímenes del género Salmonella presentan gran relevancia, esto debido a su capacidad para generar un variado espectro de manifestaciones, las cuales ven desde procesos autolimitados hasta llegar a entidades clínicas que asocian una alta morbilidad y mortalidad. El entender la inmunopatogenia de la infección por Salmonella, así como entender la variabilidad de sus formas de presentación de acuerdo con el agente causal, permite al médico establecer un abordaje idóneo; esto permitirá a su vez optimizar el proceso de diagnóstico y consecuente-mente mejorará la implementación de medidas terapéuticas necesarias para la adecuada resolución del proceso infeccioso.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mandell G.L., Bennett J.E., Dolin R. (Eds). Principles and practice of Infec-tious Diseases. Philadelphia. Churchill Livingstone. 8th Edition, 2015.

2. Dennis L. Kasper, et al (Eds). Harrison's Principles of Internal Medicine. Mcgraw-hill. 18th Edition, 2011.

3. Groisman, E., Mouslim, C. Molecular mechanisms of Salmonella pathogenesis. Current Opinion in Infectious Diseases. 2000;13:519-522

4. Li, C.W., et al. Non-typhoidal Salmone-lla bacteremia among adults: An adverse prognosis in patients with malignancy. Journal of Microbiology, Immunology and Infection. 2012;45, 343-349

5. Sánchez-Vargas, F., et al. Salmonella in-fections: An update on epidemiology, management, and prevention. Travel Medicine and Infectious Disease. 2011;9; 263-277.

6. Shimoni, Z., et al. nontyphoid salmone-lla bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clinical Infectious Disea-ses. 1999; 28:822–827

7. Deng, Z., et al. Genomic epidemiology of Salmonella enterica serotype Enteritidis based on population structure of preva-lent lineages. Emerging Infectious Di-seases. 2014; Vol. 20, No. 9: 1481-1489

8. Grassla, G.A, Finlaya, B. Pathogenesis of enteric Salmonella infections. Current Opinion in Gastroenterology. 2008; 24:22–26

9. Cook G.C. (Ed.). Manson’s. Tropical Diseases. Londres, WB Saunders Com-pany Ltd. 22th Edition, 2014.

10. Hohmann, E. Nontyphoidal Salmonello-sis. Clinical Infectious Diseases. 2001;32:263-269

11. Zhou, L., Pollard, A. A fast and highly sensitive blood culture PCR method for clinical detection of Salmonella entérica serovar Typhi. Annals of Clinical Micro-biology and Antimicrobials. 2010; 9:14.

12. Abuhasna, S. Non-Typhoidal Salmonella group D bacteremia and urosepsis in a patient diagnosed with HIV infection. Journal of Global Infectious Diseases 2012; Vol-4,Issue-4: 218-219.

13. Dhanoa, A., Fatt, Q.K. Non-typhoidal Salmonella bacteraemia: Epidemiology, clinical characteristics and its' associa-tion with severe immunosuppression. Annals of Clinical Microbiology and Antimicrobials 2009, 8:15.

14. Tang, T., et al. Reviews in Salmonella Typhimurium PhoP/PhoQ two-compo-nent regulatory system. Reviews in Me-dical Microbiology. 2013;24:18-21.

15. Lee, C.H., et al. Humoral immune res-ponses inhibit the antitumor activities mediated by Salmonella enterica serovar Choleraesuis. J Immunother. 2009; 32:376–388.

16. Groisman, E., Mouslim, C. Molecular mechanisms of Salmonella pathogenesis. Current Opinion in Infectious Diseases. 2000;13:519-522.

17. Abbott, S. Increase in extraintestinal in-fections caused by Salmonella enterica subspecies II-IV. Emerging Infectious Diseases. 2012; Vol. 18, No. 4: 637-639.

18. Bassetti, M., et al. Disseminated Salmo-nella paratyphi infection in a Rheuma-toid Arthritis patient treated with Inflixi-mab. Clin Microbiol Infect .2010; 16: 84–85

19. Chai, S.J., et al. Salmonella enterica se-rotype Enteritidis: Increasing incidence of domestically acquired infections. Cli-nical Infectious Diseases. 2012; 54(S5):S488–497.

20. Gordon, M. Salmonella infections in im-munocompromised adults. Journal of In-fection 2008; 56: 413-422.

21. Higgins, P., et al. Prior Helicobacter py-lori infection ameliorates Salmonella typhimurium-induced colitis: Mucosal crosstalk between stomach and distal in-testine. Inflamm Bowel Dis. 2011;17:1398–1408.

22. Mokhtar Arshad, M., et al. Epidemiolo-gic attributes of invasive non-typhoidal Salmonella infections in Michigan, 1995—2001. International Journal of In-fectious Diseases. 2008;12, 176-182

23. Mølbak, K., et al. Seroincidence of hu-man infections with Nontyphoid Salmo-nella compared with data from public health surveillance and food animals in 13 european countries. Clinical Infec-tious Diseases. 2014; Vol2: 627.

24. Rodicio, M.R., et al. Acquisition of anti-microbial resistance determinantsby vi-rulence plasmids specific for nontyphoid serovars of Salmonella enterica. Re-views in Medical Microbiology. 2011;22:55–65

25. Yung-Fong, T., et al. Prognostic factors and clinical features of Non-typhoid Sal-monella bacteremia in adults. J Chin Med Assoc. 2009; Vol 72,No.8: 402-407.

26. Yung-Fong, T., et al. Prognostic factors and clinical features of Non-typhoid Sal-monella bacteremia in adults. J Chin Med Assoc. 2009; Vol 72,No.8: 402-407.

27. Hsu, R.B., Lin, F.Y. Nontyphoid Salmo-nella infection in heart transplant reci-pients. Am J Med Sci. 2008; 336(5):393–396.

28. Yacoub, A., et al. Nontyphoidal Salmo-nella infections in cancer Patients. Infect Dis Clin Pract. 2014;22: 232-234.

29. Gerada, J., et al. Infectious aortitis in a liver transplant recipient. American Journal of Transplantation. 2013;13: 2479–2482.

30. Chen, P.L., et al. Extraintestinal focal in-fections in adults with nontyphoid Sal-monella bacteraemia: predisposing fac-tors and clinical outcome. J Intern Med. 2007; 261: 91–100.

31. Hsu, R.B., et al. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunode-ficiency syndrome who have Nontyphoid Salmonellosis. Clinical Infectious Disea-ses. 2003; 36:829–34.

32. Parry, C.M. Antimicrobial drug resis-tance in Salmonella enterica. Current Opinion in Infectious Diseases. 2003;16:467–472.

33. Parry, C.M., Threlfall, E.J. Antimicro-bial resistance in typhoidal and nontyphoidal salmonellae. Current Opi-nion in Infectious Diseases. 2008; 21:531–538

34. Dunne, E., et al. Emergence of domesti-cally acquired Ceftriaxone-resistant Sal-monella infections associated with -Lactamase. JAMA. 2000;Vol 284, No. 24: 3151-3156

35. Morgan, J., Laber, D. Ceftriaxone-resis-tant Salmonella septicemia and osteo-myelitis in sickle cell disease adults. Southern Medical Journal. 2006; Vo-lume 99, Number 6: 625-627

36. Varma, J., et al. Antimicrobial-resistant Nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. The Journal of Infec-tious Diseases. 2005;191:554–561

37. Weinbergera, M., Kellerb, N. Recent trends in the epidemiology of non-typhoid Salmonella and antimicrobial resistance: the Israeli experience and worldwide review. Curr Opin Infect Dis. 2005; 18:513–521

38. Raveendran, R., et al. High level cipro-floxacin resistance in salmonella enté-rica Isolated from blood. Indian Journal of Medical Microbiology, 2008; 26(1): 50-3